Josh Bilson

504 total citations · 1 hit paper
13 papers, 175 citations indexed

About

Josh Bilson is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Josh Bilson has authored 13 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Josh Bilson's work include Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (6 papers) and Pancreatitis Pathology and Treatment (4 papers). Josh Bilson is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (6 papers) and Pancreatitis Pathology and Treatment (4 papers). Josh Bilson collaborates with scholars based in United Kingdom, Italy and United States. Josh Bilson's co-authors include Christopher D. Byrne, Giovanni Targher, Alessandro Mantovani, Jaswinder K. Sethi, Eleonora Scorletti, Philip C. Calder, Laure B. Bindels, Paul R. Afolabi, Ryan Buchanan and Alessandro Csermely and has published in prestigious journals such as Gut, Metabolism and BMJ Open.

In The Last Decade

Josh Bilson

12 papers receiving 171 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Steatotic liver disease, MASLD and risk of chronic kidney disease

2023 73 citations Josh Bilson, Alessandro Mantovani et al. Diabetes & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Josh Bilson United Kingdom	7	129	64	47	30	28	13	175
Hong Kai Lim United Kingdom	5	118 0.9×	49 0.8×	39 0.8×	38 1.3×	35 1.3×	10	158
Ornella Verrastro Italy	9	146 1.1×	89 1.4×	70 1.5×	39 1.3×	48 1.7×	14	227
Pomme I. H. G. Simons Netherlands	9	153 1.2×	148 2.3×	58 1.2×	26 0.9×	15 0.5×	15	266
Cameron Gofton Australia	5	238 1.8×	122 1.9×	43 0.9×	51 1.7×	77 2.8×	9	303
Jacob George Australia	5	246 1.9×	116 1.8×	46 1.0×	44 1.5×	95 3.4×	17	322
Yansong Lin China	11	209 1.6×	110 1.7×	51 1.1×	28 0.9×	95 3.4×	18	255
Nicole Aumann Germany	7	76 0.6×	115 1.8×	26 0.6×	41 1.4×	8 0.3×	8	236
Seham Noureldin Canada	4	237 1.8×	79 1.2×	44 0.9×	65 2.2×	127 4.5×	4	285
Soroor Owrangi United States	5	181 1.4×	114 1.8×	42 0.9×	33 1.1×	50 1.8×	5	225
Korenobu Hayama Japan	7	98 0.8×	55 0.9×	23 0.5×	25 0.8×	61 2.2×	14	145

Countries citing papers authored by Josh Bilson

Since Specialization

Citations

This map shows the geographic impact of Josh Bilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josh Bilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josh Bilson more than expected).

Fields of papers citing papers by Josh Bilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josh Bilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josh Bilson. The network helps show where Josh Bilson may publish in the future.

Co-authorship network of co-authors of Josh Bilson

This figure shows the co-authorship network connecting the top 25 collaborators of Josh Bilson. A scholar is included among the top collaborators of Josh Bilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josh Bilson. Josh Bilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Cuthbertson, Daniel J., Oliver Kennedy, Josh Bilson, et al.. (2025). Impact of metabolic dysfunction severity in steatotic liver disease and its interaction with liver fibrosis on all-cause mortality and multiple hepatic and extra-hepatic outcomes. Metabolism. 170. 156306–156306. 4 indexed citations

Buchanan, Ryan, Josh Bilson, Keith Cooper, et al.. (2025). Screening to identify people with type 2 diabetes at risk of liver cancer in primary care: a randomised controlled trial protocol. BMJ Open. 15(3). e088043–e088043. 2 indexed citations

Bilson, Josh, Daniel J. Cuthbertson, & Christopher D. Byrne. (2025). Evolving models of care in patients with metabolic dysfunction-associated steatotic liver disease, recognising its population burden and the impact of metabolic dysfunction on incident rates of hepatic and extrahepatic outcomes. ePrints Soton (University of Southampton). 5(2).

Mantovani, Alessandro, Fabiana Busti, Alessandro Csermely, et al.. (2024). Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study. Cardiovascular Diabetology. 23(1). 305–305. 2 indexed citations

Bilson, Josh, Theresa Hydes, Ryan Buchanan, et al.. (2024). Impact of Metabolic Syndrome Traits on Kidney Disease Risk in Individuals with MASLD : A UK Biobank Study. Liver International. 45(4). e16159–e16159. 8 indexed citations

Mantovani, Alessandro, Alessandro Csermely, Josh Bilson, et al.. (2024). Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut. 73(9). 1554–1561. 12 indexed citations

Bilson, Josh, Eleonora Scorletti, Jonathan R. Swann, & Christopher D. Byrne. (2024). Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases. Biomolecules. 14(7). 841–841. 4 indexed citations

Bilson, Josh, Eleonora Scorletti, Paul R. Afolabi, et al.. (2023). Markers of adipose tissue fibrogenesis associate with clinically significant liver fibrosis and are unchanged by synbiotic treatment in patients with NAFLD. Metabolism. 151. 155759–155759. 9 indexed citations

Bilson, Josh, Alessandro Mantovani, Christopher D. Byrne, & Giovanni Targher. (2023). Steatotic liver disease, MASLD and risk of chronic kidney disease. Diabetes & Metabolism. 50(1). 101506–101506. 73 indexed citations breakdown →

10.

Bilson, Josh, Jaswinder K. Sethi, & Christopher D. Byrne. (2023). Heterogeneity of white adipocytes in metabolic disease. Current Opinion in Clinical Nutrition & Metabolic Care. 26(2). 72–77. 9 indexed citations

11.

Bilson, Josh & Eleonora Scorletti. (2023). Lipid droplets in steatotic liver disease. Current Opinion in Clinical Nutrition & Metabolic Care. 27(2). 91–97. 4 indexed citations

12.

Bilson, Josh, Jaswinder K. Sethi, & Christopher D. Byrne. (2021). Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function. Proceedings of The Nutrition Society. 81(2). 146–161. 27 indexed citations

13.

Bilson, Josh, Eleonora Scorletti, Laure B. Bindels, et al.. (2021). Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD. Nutrition and Diabetes. 11(1). 32–32. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact